» Articles » PMID: 25115875

Peri-operative Kidney Injury and Long-term Chronic Kidney Disease Following Orthotopic Heart Transplantation in Children

Overview
Journal Pediatr Nephrol
Specialties Nephrology
Pediatrics
Date 2014 Aug 14
PMID 25115875
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Significant advances in cardiac intensive care including extracorporeal life support have enabled children with complex congenital heart disease and end-stage heart failure to be supported while awaiting transplantation. With an increasing number of survivors after heart transplantation in children, the complications from long-term immunosuppression, including renal insufficiency, are becoming more apparent. Severe renal dysfunction after heart transplant is defined by a serum creatinine level >2.5 mg/dL (221 μmol/L), and/or need for dialysis or renal transplant. The degree of renal dysfunction is variable and is progressive over time. About 3-10 % of heart transplant recipients will go on to develop severe renal dysfunction within the first 10 years post-transplantation. Multiple risk factors for chronic kidney disease post-transplant have been identified, which include pre-transplant worsening renal function, recipient demographics and morbidity, peri-transplant haemodynamics and long-term exposure to calcineurin inhibitors. Renal insufficiency increases the risk of post-transplant morbidity and mortality. Hence, screening for renal dysfunction pre-, peri- and post-transplantation is important. Early and timely detection of renal insufficiency may help minimize renal insults, and allow prompt implementation of renoprotective strategies. Close monitoring and pre-emptive management of renal dysfunction is an integral aspect of peri-transplant and subsequent post-transplant long-term care.

Citing Articles

Acute Kidney Injury in Pediatric Heart Failure.

Riley A, Gebhard D, Akcan-Arikan A Curr Cardiol Rev. 2015; 12(2):121-31.

PMID: 26585035 PMC: 4861941. DOI: 10.2174/1573403x12666151119165628.

References
1.
Leenen F, Coletta E, Davies R . Prevention of renal dysfunction and hypertension by amlodipine after heart transplant. Am J Cardiol. 2007; 100(3):531-5. DOI: 10.1016/j.amjcard.2007.03.058. View

2.
Prodhan P, Bhutta A, Gossett J, Dodgen A, Seib P, Imamura M . Comparative effects of ventricular assist device and extracorporeal membrane oxygenation on renal function in pediatric heart failure. Ann Thorac Surg. 2013; 96(4):1428-1434. DOI: 10.1016/j.athoracsur.2013.05.083. View

3.
Benden C, Edwards L, Kucheryavaya A, Christie J, Dipchand A, Dobbels F . The Registry of the International Society for Heart and Lung Transplantation: fifteenth pediatric lung and heart-lung transplantation report--2012. J Heart Lung Transplant. 2012; 31(10):1087-95. DOI: 10.1016/j.healun.2012.08.005. View

4.
Wuhl E, Trivelli A, Picca S, Litwin M, Peco-Antic A, Zurowska A . Strict blood-pressure control and progression of renal failure in children. N Engl J Med. 2009; 361(17):1639-50. DOI: 10.1056/NEJMoa0902066. View

5.
Kofler S, Bigdeli A, Kaczmarek I, Kellerer D, Muller T, Schmoeckel M . Long-term outcomes after 1000 heart transplantations in six different eras of innovation in a single center. Transpl Int. 2009; 22(12):1140-50. DOI: 10.1111/j.1432-2277.2009.00931.x. View